You can buy or sell CYCC and other stocks, options, ETFs, and crypto commission-free!
Cyclacel Pharmaceuticals, Inc. Common Stock, also called Cyclacel Pharmaceuticals, is a clinical-stage biopharmaceutical company. Read More It uses cell cycle, transcriptional regulation and DNA damage response biology to develop innovative, targeted medicines for cancer and other proliferative diseases. The company builds a diversified biopharmaceutical business, which is focused in hematology and oncology based on a pipeline of novel drug candidates. Its products includes CYC065, seliciclib, and sapacitabine. The company was founded by Ronald J. Berenson, David Philip Lane, and David Glover on August 13, 1996 and is headquartered in Berkeley Heights, NJ.
Berkeley Heights, New Jersey
52 Week High
52 Week Low
Simply Wall StMar 12
Should You Be Pleased About The CEO Pay At Cyclacel Pharmaceuticals, Inc.’s (NASDAQ:CYCC)
Spiro Rombotis became the CEO of Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) in 1997. This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies of similar size. Then we’ll look at a snap shot of the business growth. And finally – as a second measure of performance – we will look at the returns shareholders have received over the last few years. This method should give us information to assess how appropriately the company pays the CEO. Check out our latest...
Available Mar 27, After Hours